Consultation record
Submissions accepted — page 8
The submission is accepted and the draft is amended as proposed. The amendment is recorded in the amendment log of the document it changed and is traceable to the numbered submission.
Submissions
681 documents · page 8 of 23
Table 1. Submissions with this disposition, on this page.
| Reference | Consultation | Respondent | Point raised |
|---|---|---|---|
| DRAFT-SEARCH-STRAT/012 | Draft search-strategy template for the synthesis series | Gaspard Kettlewell | The same concept is given three different names in one document |
| DRAFT-SEARCH-STRAT/010 | Draft search-strategy template for the synthesis series | Dr Rosalind Grünbaum-Sowande | Protocol amendments are permitted without a requirement to record when they were made |
| DRAFT-SEARCH-STRAT/019 | Draft search-strategy template for the synthesis series | Dr Frideswide Grünbaum-Sowande | Quantitative claims are reproduced without the method that produced them |
| DRAFT-PRINT-AND-AR/013 | Draft print and archival format for Institute documents | Dr Rurik Haverkamp-Diallo | There is no route to challenge a disposition |
| DRAFT-PRINT-AND-AR/010 | Draft print and archival format for Institute documents | Leonhard Achterberg | What the site collects about a reader is not stated in terms a reader can check |
| DRAFT-PRINT-AND-AR/012 | Draft print and archival format for Institute documents | Dr Rosalind Grünbaum-Sowande industry | Two factual descriptions of the sponsor's programme are inaccurate |
| DRAFT-PRINT-AND-AR/017 | Draft print and archival format for Institute documents | Nkechi Larsson-Ekwueme | Quantitative claims are reproduced without the method that produced them |
| DRAFT-PRINT-AND-AR/009 | Draft print and archival format for Institute documents | Dr Ndidi Ravensworth-Ilunga | Absence of evidence is presented in a form a reader will take as negative evidence |
| DRAFT-PRINT-AND-AR/016 | Draft print and archival format for Institute documents | Xenia Nyquist-Obiora | Where a document is generated rather than authored, the reader should be told |
| DRAFT-PRINT-AND-AR/004 | Draft print and archival format for Institute documents | Dr Lorcan Whitmarsh-Obi | The terms on which the documents may be reused are not stated |
| DRAFT-PRINT-AND-AR/015 | Draft print and archival format for Institute documents | Dr Rurik Underhill-Okafor | Disagreement within the assessment committee is not visible |
| DRAFT-CERTAINTY-IN/004 | Draft certainty index | Dr Fenella Lavrentiev | Absence of evidence is presented in a form a reader will take as negative evidence |
| DRAFT-CERTAINTY-IN/001 | Draft certainty index | Dr Wilhelmina Wintringham industry | Two factual descriptions of the sponsor's programme are inaccurate |
| DRAFT-CERTAINTY-IN/003 | Draft certainty index | Ludmila Brackenridge | Indications for which compounds are supplied are absent from the set |
| DRAFT-CERTAINTY-IN/015 | Draft certainty index | Dr Theodora Trelawney | An identifier that encodes the document type will have to change when the type does |
| DRAFT-CERTAINTY-IN/010 | Draft certainty index | Dr Quintus Rautavaara | The same quantity is presented differently in two series |
| DRAFT-CERTAINTY-IN/009 | Draft certainty index | Dr Gervase Crickhowell | The index shows ratings without the reasons behind them |
| DRAFT-CERTAINTY-IN/012 | Draft certainty index | Dr Yaa Kettlewell | The registry is published only as pages and not in a form that can be processed |
| DRAFT-CERTAINTY-IN/008 | Draft certainty index | Dr Frideswide Nordhagen | The search date is not on the face of the document |
| DRAFT-CERTAINTY-IN/011 | Draft certainty index | Vasilisa Sandringham-Adu | A withdrawn document should not simply disappear |
| DRAFT-CERTAINTY-IN/007 | Draft certainty index | Dr Valentin Castellanos-Reid | The default ordering of a comparison table carries an implication |
| DRAFT-AMYCRETIN-MO/008 | Draft monograph: amycretin | Dr Frideswide Nordhagen | The compound is supplied under names the monograph does not list |
| DRAFT-AMYCRETIN-MO/016 | Draft monograph: amycretin | Dr Mordecai Bellingham-Ojo | The monograph does not tell a reader that a stated mass may be substantially counter-ion and water |
| DRAFT-AMYCRETIN-MO/011 | Draft monograph: amycretin | Dr Yehudit Yorkstone | The search date is not on the face of the document |
| DRAFT-AMYCRETIN-MO/002 | Draft monograph: amycretin | Dr Hamish Nyquist-Obiora | Quantitative claims are reproduced without the method that produced them |
| DRAFT-AMYCRETIN-MO/015 | Draft monograph: amycretin | Dr Jacinta Steenkamp-Ferreira | Evidence for one member of the class is presented as evidence for this compound |
| DRAFT-AMYCRETIN-MO/003 | Draft monograph: amycretin | Ludmila Brackenridge | Doses are expressed in units that differ between sections |
| DRAFT-AMYCRETIN-MO/009 | Draft monograph: amycretin | Dr Liesbeth Zaleski-Mbeki | Regulatory status is stated without naming the jurisdiction |
| DRAFT-AMYCRETIN-MO/004 | Draft monograph: amycretin | Dr Fenella Lavrentiev | The certainty rating for the principal assessed outcome cannot be traced to the contributing trials |
| DRAFT-5-AMINO-1MQ-/005 | Draft monograph: 5-amino-1MQ | Dr Katarzyna Yorkstone | The compound is supplied under names the monograph does not list |
page 8 of 23